MedElevator Войти в исследования
← Поиск публикаций

DOI 10.14309/ajg.0000000000004056

Медицинская библиотека · The American journal of gastroenterology · 2026

Microbiome-Directed Therapy for Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Placebo-Controlled Trial of Multistrain Probiotic Supplementation.

Borren Nienke Z, Paulides Emma, Klaassen Marjolein A Y, Alm Eric, Xavier Ramnik J, van der Woude C Janneke, Ananthakrishnan Ashwin N

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Fatigue is a challenging symptom for patients with inflammatory bowel diseases (IBD). Emerging evidence links alterations in the gut microbiome with fatigue in IBD, highlighting the potential of microbiome-targeted treatments. Our aim was to evaluate the clinical efficacy and biological effects of a multistrain probiotic supplementation on fatigue in patients with quiescent IBD.

METHODS

This multicenter, placebo-controlled, randomized controlled trial included patients with quiescent IBD, defined as being in clinical remission and a colonoscopy within 1 year which demonstrated no active disease, and with significant fatigue (Functional Assessment of Chronic Illness Therapy-Fatigue score ≤43). Patients were randomized to receive either probiotics (Ecologic BARRIER, containing 9 different bacterial strains) or placebo for 12 weeks. Gut microbiome and serum metabolome were analyzed at baseline and at the end of the study.

RESULTS

Our study enrolled 100 patients (52 Crohn's disease, 44 ulcerative colitis, 4 IBD-unspecified) with quiescent IBD and with a mean age of 41 years; 61% were women. After 12 weeks, 29.4% of the probiotic group and 40.0% of the placebo group met criteria for no fatigue ( P = 0.34). However, all participants reported an improvement in fatigue ( P < 0.001) with the most striking change noted at 4 weeks in both groups. Probiotic treatment led to beneficial shifts in gut microbiome and serum metabolome composition, particularly an increase in Bifidobacterium animalis after 12 weeks.

DISCUSSION: Although 12 weeks of probiotic administration was not associated with relief of fatigue in patients with quiescent IBD, we observed beneficial alterations in the gut microbiome and serum metabolome.

Для цитирования: Borren Nienke Z, Paulides Emma, Klaassen Marjolein A Y, Alm Eric, Xavier Ramnik J, van der Woude C Janneke, Ananthakrishnan Ashwin N. Microbiome-Directed Therapy for Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Placebo-Controlled Trial of Multistrain Probiotic Supplementation.. The American journal of gastroenterology. 2026. DOI: 10.14309/ajg.0000000000004056.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.